Bayer AG – Enterprise Tech Ecosystem Series
Powered by
All the vital news, analysis, and commentary curated by our industry experts.
Bayer implemented a five-year global IT strategy to drive its digital business transformation by aligning itself to new technologies like cloud, IoT, and AI among others, and using them to create various digital platforms.
Bayer is digitally transforming its internal operations to improve productivity and efficiency and have cost-effective functional areas. For example, it deployed a digital twin-based scheduling program at its pharma manufacturing site in Italy, bringing improvements in its quality-control lab, and transforming it into a smart factory.
Bayer is using 3D printing to manufacture plastic face shields, ventilator components, and other personal protection equipment parts for healthcare workers. The company has increased its capacity to produce up to 500 medical face shields a day using 3D printing technology.
The report provides information and insights into Bayer's technology activities, including –
– Insights of its digital transformation strategies and accelerator & digital innovation programs
– Overview of technology initiatives covering strategic partnerships and product launches
– Details of investments in companies providing innovative solutions
– Insights on each technology initiative including technology theme, objective, and benefits
– Details of estimated ICT budgets and contracts
Scope
– The key technology themes under focus for Bayer are 3D printing, artificial intelligence, augmented & virtual reality, big data, blockchain, cybersecurity, healthtech, IoT, mobile health, and robotics.
– Bayer partnered and invested mainly in companies which would enable it to optimize its drug discovery and IT operational procedures.
– In consumer health area, digital health model can enable Bayer to bring new medicines to patients faster, help healthcare providers get right diagnosis and personalize treatments to individuals, and bring new non-pharma solutions. Bayer is leveraging digital technologies to diagnose diseases with more precision and in less time, and provide timely, personalized treatments.
Reasons to Buy
– Gain insights into Bayer's technology operations.
– Gain insights into its tech strategies and innovation initiatives.
– Gain insights into its technology themes under focus.
– Gain insights into various product launches, partnerships, and investments of Bayer.
BlueRock Therapeutics
Joyn Bio
Khloris Biosciences
Century Therapeutics
Pyxis Oncology
Joyn Bio
Gingko Bioworks
Exscientia
Sensyne Health
Merck
Genpact
Imperial College London
SlantRange
BlockApps
Amino Payments
Allianz
Volkswagen
BASF
Tata Consultancy Services
NRGene
iControl Data Solutions
Atos
RWTH Aachen University
Wiivv
Samsung
Travelers Insurance
Cedars-Sinai Medical Center
AppliedVR
DJM PAN
Pilloxa
ABB
MSK
Berkeley Lights
Loccioni
Istituto Italiano di Tecnologia (IIT)
CommerceIQ
AliHealth
eGenesis
Immunitas Therapeutics
One Drop
Medopad (now called Huma)
Atomwise
Z21 Labs (Observe.AI)
Capgemini
Table of Contents
Frequently asked questions
Get in touch to find out about multi-purchase discounts
reportstore@globaldata.com
Tel +44 20 7947 2745
Every customer’s requirement is unique. With over 220,000 construction projects tracked, we can create a tailored dataset for you based on the types of projects you are looking for. Please get in touch with your specific requirements and we can send you a quote.
Related reports
View more Technology reports

